SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics. It offers tests detecting the Mycoplasma genitalium and gonorrhea infection, as well as genetic markers linked to macrolide antibiotic resistance and susceptibility to ciprofloxacin. The company also provides SpeeDx automation solutions, controls and auxiliary products, and research reagents.